Guangzhou Gloria Biosciences Co., Ltd., commonly referred to as Gloria Biosciences, is a leading player in the biotechnology industry, headquartered in Guangzhou, China. Established in 2009, the company has made significant strides in the development of innovative biopharmaceuticals and diagnostic products, focusing on areas such as molecular diagnostics and therapeutic solutions. With a commitment to quality and innovation, Gloria Biosciences offers a range of unique products, including advanced reagents and diagnostic kits that cater to both clinical and research applications. The company has positioned itself as a trusted partner in the global market, achieving notable milestones in research and development. Its dedication to excellence has earned it recognition within the industry, solidifying its reputation as a key contributor to the advancement of biosciences.
How does Guangzhou Gloria Biosciences Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Guangzhou Gloria Biosciences Co., Ltd.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Guangzhou Gloria Biosciences Co., Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that the organisation may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it is essential for companies like Guangzhou Gloria Biosciences to consider setting measurable targets and participating in climate action frameworks to enhance their environmental responsibility.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guangzhou Gloria Biosciences Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

